Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Updated on: December 28,2023

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Updated on:December 28,2023

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on: December 25,2023

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on:December 25,2023

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on: January 25,2024

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on:January 25,2024

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns

Updated on: December 20,2023

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns

Updated on:December 20,2023

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o

Updated on: November 30,2024

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o

Updated on:November 30,2024

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on: January 25,2024

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on:January 25,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on: January 23,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on:January 23,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on: March 30,2024

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on:March 30,2024

Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how

Updated on: January 30,2024

Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how

Updated on:January 30,2024

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on: May 09,2024

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on:May 09,2024